statements

HPC Biosciences Ltd.

BSE: 535217

Sector: Fast Moving Consumer Goods

Industry Group: Agricultural Food & other Products

Industry: Other Agricultural Products

25.68+0.0 (+0.00%)

11 Nov, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

HPC Biosciences Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2010 Mar 31	2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31
	2010 Mar 31	2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31
Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M PRESS
Total Revenue	-	-	2.90	4.76	3.46	3.09	1.87	2.26	1.94	1.60	1.20	2.29	0.49	0.21
Cost of Operating Revenue	-	-	-0.42	1.16	1.67	1.84	0.86	1.10	1.14	0.76	0.69	0.77	1.05	0.50
Gross Profit	-	-	3.32	3.60	1.79	1.25	1.01	1.15	0.80	0.85	0.51	1.52	-0.56	-0.29
Gross Margin	-	-	114.5	75.7	51.7	40.6	54.2	51.1	41.2	52.8	42.7	66.4	-114.5	-138.1
Total Operating Expenses	0.00	0.00	-0.15	1.79	2.27	2.51	1.51	1.88	1.85	1.11	0.94	1.18	1.39	0.73
Operating Profit	0.00	0.00	3.05	2.97	1.19	0.59	0.36	0.38	0.09	0.49	0.26	1.11	-0.90	-0.52
Operating Margin	-	-	105.2	62.4	34.4	19.0	19.4	16.8	4.8	30.5	21.4	48.4	-183.3	-247.9
Financing Income/(Expense) - Net	-	-	-	0.01	-	-	-	-	-	-	-	-	-	-
Profit before Taxes	0.00	0.00	3.05	2.98	1.26	0.76	0.50	0.57	0.23	0.58	0.36	1.19	-0.48	0.03
Income Taxes	-	-	-	0.00	0.02	0.05	0.04	0.06	0.03	0.02	0.02	0.02	0.01	0.01
Profit after Tax	0.00	0.00	3.05	2.98	1.24	0.71	0.46	0.51	0.20	0.55	0.34	1.17	-0.49	0.02
PAT Margin	-	-	105.2	62.5	35.7	22.8	24.7	22.5	10.1	34.6	28.1	51.2	-100.9	10.0
EPS - Basic - ex Extraordinary Items	-	-	0.19	0.19	0.08	0.04	0.03	0.03	0.01	0.03	0.02	0.07	-0.03	0.00
EPS - Diluted - ex Extraordinary Items	-	-	0.19	0.19	0.08	0.04	0.03	0.03	0.01	0.03	0.02	0.07	-0.03	0.00
EBIT	0.00	0.00	3.05	2.97	1.19	0.59	0.36	0.38	0.09	0.49	0.26	1.11	-0.90	-0.52
EBITDA	0.00	0.00	3.18	4.30	2.55	2.00	1.74	1.37	0.94	1.20	0.87	1.62	-0.40	-0.02
EBITDA Margin	-	-	109.6	90.3	73.7	64.6	93.4	60.7	48.1	75.2	72.2	70.8	-80.7	-9.8

Balance Sheet

Abridged

Understanding Balance Sheet

HPC Biosciences Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2010 Mar 31	2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31
	2010 Mar 31	2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31
Source:	PR	PR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS	PRESS
Total Current Assets	0.05	0.05	1.23	10.84	13.04	17.27	19.25	21.17	22.34	23.72	24.57	26.07	26.07	26.13
Long-Term Investments	0.03	0.03	-	-	2.79	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30
Property Plant & Equipment - Net	-	-	1.10	10.57	9.53	8.12	6.74	5.75	4.91	4.19	3.58	3.07	2.57	2.06
Total Non-Current Assets	0.03	0.03	3.56	16.99	16.36	12.44	10.94	9.83	8.92	8.18	7.57	7.06	6.55	6.05
Total Assets	0.08	0.08	4.80	27.83	29.40	29.70	30.19	31.00	31.26	31.90	32.14	33.13	32.62	32.18
Total Current Liabilities	0.00	0.00	0.00	0.14	0.48	0.08	0.10	0.40	0.47	0.56	0.46	0.28	0.27	0.26
Long Term Debt	0.03	0.03	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	0.03	0.03	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	0.03	0.03	0.00	0.14	0.48	0.08	0.10	0.40	0.47	0.56	0.46	0.28	0.27	0.26
Total Shareholders' Equity	0.05	0.05	4.80	27.68	28.92	29.63	30.09	30.59	30.79	31.34	31.68	32.85	32.36	31.92
Total Equity	0.05	0.05	4.80	27.68	28.92	29.63	30.09	30.59	30.79	31.34	31.68	32.85	32.36	31.92
Total Liabilities & Equity	0.08	0.08	4.80	27.83	29.40	29.70	30.19	31.00	31.26	31.90	32.14	33.13	32.62	32.18

Cash Flow

Abridged

Understanding Cash Flow Statement

HPC Biosciences Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2010 Mar 31	2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	R 2021 Mar 31	2022 Mar 31	2023 Mar 31
	2010 Mar 31	2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	R 2021 Mar 31	2022 Mar 31	2023 Mar 31
Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR	12M PRESS	12M PRESS
Operating CF bef Changes in Working Cap	0.00	0.00	0.00	0.00	2.71	2.28	1.97	1.65	1.04	1.31	0.97	1.70	0.02	0.09
Working Capital - Increase/(Decrease)	-	-	0.00	0.00	1.35	-1.89	-2.02	-0.38	-0.82	-0.05	-0.04	-0.24	0.48	-0.07
Net CF from Operating Activities	0.00	0.00	0.00	0.00	4.06	0.39	-0.04	1.28	0.22	1.26	0.92	1.46	0.50	0.02
Capital Expenditures - Net	-	-	0.00	0.01	0.33	-	-	-	-	-	-	-	-	-
Net CF from Investing Activities	-	-	0.00	-0.02	-4.59	0.50	0.02	-2.05	-0.24	-1.05	-0.89	-1.46	0.39	-0.73
Stock - Issuance/(Retirement) - Net	-	-	0.00	0.02	-	-	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-	-	-	0.00	0.28	-0.38	-	-	-	-	-	-	-	-
Net Cash Flow from Financing Activities	-	-	0.00	0.02	0.28	-0.47	-	-	-	-	-	-	-	-
Free Cash Flow to Equity	0.00	0.00	0.00	-0.01	4.01	0.01	-0.04	1.28	0.22	1.26	0.92	1.46	0.50	0.02
Free Operating CF net dividend	0.00	0.00	0.00	-0.01	3.73	0.39	-0.04	1.28	0.22	1.26	0.92	1.46	0.50	0.02
Free Operating CF	0.00	0.00	0.00	-0.01	3.73	0.39	-0.04	1.28	0.22	1.26	0.92	1.46	0.50	0.02

Business Segment Analysis

HPC Biosciences Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for HPC Biosciences Ltd.

Regional Segment Analysis

HPC Biosciences Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for HPC Biosciences Ltd.

Historical Segment Analysis

Track how HPC Biosciences Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for HPC Biosciences Ltd.

Frequently Asked Questions

What is the revenue of HPC Biosciences Ltd.?

The latest trailing twelve month revenue of HPC Biosciences Ltd. is -. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of HPC Biosciences Ltd.?

The latest trailing twelve month net profit (PAT) of HPC Biosciences Ltd. is -. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of HPC Biosciences Ltd.?

The operating margin of HPC Biosciences Ltd. is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of HPC Biosciences Ltd.?

The trailing twelve month Earnings Per Share (EPS) of HPC Biosciences Ltd. is -. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of HPC Biosciences Ltd.?

The debt-to-equity ratio of HPC Biosciences Ltd. stands at -. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of HPC Biosciences Ltd.?

The book value per share of HPC Biosciences Ltd. is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of HPC Biosciences Ltd.?

Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does HPC Biosciences Ltd. report consolidated or standalone financials?

HPC Biosciences Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.